» Authors » Christelle Faveeuw

Christelle Faveeuw

Explore the profile of Christelle Faveeuw including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 53
Citations 1740
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Matarazzo L, Costa C, Porte R, Saliou J, Figeac M, Delahaye F, et al.
Mucosal Immunol . 2024 Nov; 18(1):257-268. PMID: 39592068
Host-directed therapy, using nasal administration of the Toll-like receptor 5 agonist flagellin in combination with antibiotics, has proven effective against pneumococcal pneumonia. In this study, we investigated the immune mechanisms...
2.
Creusat F, Jouan Y, Gonzalez L, Barsac E, Ilango G, Lemoine R, et al.
Sci Adv . 2024 Oct; 10(41):eadn3257. PMID: 39392875
Neutrophil subsets endowed with regulatory/suppressive properties are widely regarded as deleterious immune cells that can jeopardize antitumoral response and/or antimicrobial resistance. Here, we describe a sizeable fraction of neutrophils characterized...
3.
Mondeme M, Zeroual Y, Soulard D, Hennart B, Beury D, Saliou J, et al.
J Leukoc Biol . 2023 Oct; 115(3):463-475. PMID: 37837383
Pneumonia caused by Streptococcus pneumoniae is a leading cause of death worldwide. A growing body of evidence indicates that the successful treatment of bacterial infections results from synergy between antibiotic-mediated...
4.
Mondeme M, Carnoy C, Sirard J, Faveeuw C
Infect Immun . 2023 Jan; 91(2):e0050322. PMID: 36695576
β-Lactams are the most widely prescribed antibiotics used for the control and treatment of bacterial infections. The direct effect of β-lactams on bacteria is well studied worldwide. In the context...
5.
Dessein R, Bauduin M, Grandjean T, Le Guern R, Figeac M, Beury D, et al.
Crit Care . 2020 Oct; 24(1):611. PMID: 33076936
Background: Gut dysbiosis due to the adverse effects of antibiotics affects outcomes of lung infection. Previous murine models relied on significant depletion of both gut and lung microbiota, rendering the...
6.
Ayari A, Rosa-Calatrava M, Lancel S, Barthelemy J, Pizzorno A, Mayeuf-Louchart A, et al.
Commun Biol . 2020 May; 3(1):237. PMID: 32409640
Like all obligate intracellular pathogens, influenza A virus (IAV) reprograms host cell's glucose and lipid metabolism to promote its own replication. However, the impact of influenza infection on white adipose...
7.
Sencio V, Barthelemy A, Tavares L, G Machado M, Soulard D, Cuinat C, et al.
Cell Rep . 2020 Mar; 30(9):2934-2947.e6. PMID: 32130898
Secondary bacterial infections often complicate viral respiratory infections. We hypothesize that perturbation of the gut microbiota during influenza A virus (IAV) infection might favor respiratory bacterial superinfection. Sublethal infection with...
8.
Hassane M, Jouan Y, Creusat F, Soulard D, Boisseau C, Gonzalez L, et al.
Mucosal Immunol . 2019 Oct; 13(1):128-139. PMID: 31628425
Interleukin-7 (IL-7) is a critical cytokine in B- and T-lymphocyte development and maturation. Recent evidence suggests that IL-7 is a preferential homeostatic and survival factor for RORγt innate T cells...
9.
Matarazzo L, Casilag F, Porte R, Wallet F, Cayet D, Faveeuw C, et al.
Front Immunol . 2019 Apr; 10:723. PMID: 31024555
Bacterial infections of the respiratory tract constitute a major cause of death worldwide. Given the constant rise in bacterial resistance to antibiotics, treatment failure is increasingly frequent. In this context,...
10.
Paget C, Deng S, Soulard D, Priestman D, Speca S, von Gerichten J, et al.
PLoS Biol . 2019 Mar; 17(3):e3000169. PMID: 30822302
CD1d-restricted invariant natural killer T (iNKT) cells represent a heterogeneous population of lipid-reactive T cells that are involved in many immune responses, mediated through T-cell receptor (TCR)-dependent and/or independent activation....